Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Equities research analysts at Seaport Res Ptn dropped their Q2 2025 earnings per share estimates for shares of Green Thumb Industries in a research note issued on Monday, May 12th. Seaport Res Ptn analyst S. Randhawa now anticipates that the company will post earnings of $0.01 per share for the quarter, down from their prior forecast of $0.02. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share. Seaport Res Ptn also issued estimates for Green Thumb Industries' Q3 2025 earnings at $0.01 EPS, Q4 2025 earnings at $0.02 EPS, FY2025 earnings at $0.08 EPS, Q1 2026 earnings at $0.02 EPS, Q2 2026 earnings at $0.02 EPS, Q4 2026 earnings at $0.03 EPS and FY2026 earnings at $0.10 EPS.
Green Thumb Industries Price Performance
Shares of Green Thumb Industries stock opened at $5.44 on Tuesday. Green Thumb Industries has a one year low of $4.63 and a one year high of $14.30. The stock's 50-day moving average is $5.79 and its 200 day moving average is $7.28. The firm has a market cap of $1.15 billion, a price-to-earnings ratio of 22.67 and a beta of 1.32.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.01). Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%. The business had revenue of $279.54 million for the quarter, compared to the consensus estimate of $283.36 million.
Green Thumb Industries Company Profile
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
